display ongoing
results: demonstrated suggested inconclusive safety concern ongoing study
metastatic/advanced mGC or mGEJC
mGC or mGEJC - L1 - PDL1 positivemGC or mGEJC - L2 - all populationmGC or mGEJC - L2 - PDL1 positive
pembrolizumab alone KEYNOTE-062 ... KEYNOTE-062 ... KEYNOTE-061 ... KEYNOTE-061 ...

Study type:

 

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons